Zimbabwe’s Ministry of Health and Child Care has issued an official recall for two batches of Nifedipine 10mg, a medication commonly prescribed for high blood pressure, after routine quality checks uncovered stability problems.
The affected supplies, identified as batch numbers 112033 and 117367, were produced by Cyprus-based pharmaceutical company Remedica Ltd. The recall notice was confirmed in a ministry statement released on September 12.
According to the Medicines Control Authority of Zimbabwe (MCAZ), the decision follows a Class Two classification, which requires withdrawal of the product from all retail pharmacies, hospitals, and even patients who may already possess it.
The regulator added that the same round of testing also raised concerns about Levodopa/Carbidopa tablets, another Remedica product used in the treatment of Parkinson’s disease and related conditions.
Patients currently using Nifedipine from the recalled batches are advised to stop taking the tablets immediately and return them to their nearest health facility or pharmacy. The ministry says the recall is part of its ongoing post-market surveillance programme to protect public health.
